Skip to content
Monday, 16 November 2026
Search
Archive
Night edition
News
Features
Opinion
Reports
Tracker
Archive
Newsletter
Archive
2024
60 pieces.
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
20 December 2024
Lyphe Launches V Range: Affordable, Reliable, and Future-Ready Medical Cannabis
News · Paul North
12 December 2024
Germany’s Cannabis Pilot Programme: A Transformative Step for Europe’s Industry
News · Paul North
1 October 2024
Kamala Harris’ Support for Cannabis Legalisation: What It Could Mean for the Future of US Drug Policy
News · Volteface
1 October 2024
Stigma and Inequality: The Hidden Harms Faced by UK Cannabis Patients
News · Volteface
16 September 2024
Is Ketamine Use Among Young People in the UK a Growing Crisis?
News · Volteface
12 September 2024
New MHRA Guidelines Set to Impact Medical Cannabis Product Registration and Labelling
News · Paul North
9 September 2024
MedBud’s August 2024 UK Cannabis Market Data: Clinics, Flower, Pharmacies and Oils
News · Paul North
5 September 2024
Government’s Stigmatising Language in the Xylazine Ban: A Harmful Misstep
News · Paul North
4 September 2024
Landlords Risk Legal Trouble Over Prescription Cannabis Accommodations
News · Paul North
3 September 2024
Trump’s New Strategy on Cannabis: A Political Game-Changer?
News · Paul North
2 September 2024
Labour’s Proposed Vape Ban Is a Blow to Harm Reduction
News · Paul North
31 August 2024
Overdose Awareness Day: A crucial reminder of the need for policy reform
News · Paul North
30 August 2024
UK Medical Cannabis: The Challenges of Reaching 300,000 Patients by 2028
News · Paul North
29 August 2024
Why Labour’s Proposed Smoking Ban Is an Attack on Personal Freedom and Common Sense
News · Paul North
28 August 2024
Critical DEA cannabis hearing delayed due to 43,500 public comments
News · Paul North
28 August 2024
New Data Shows Legalisation Reduces Cannabis Use—The UK Should Take Note
News · Paul North
28 August 2024
Ukraine’s Medical Cannabis Laws Need to Reflect the Realities of War
News · Paul North
9 August 2024
From Illicit to Legal: What Will It Take to Win Over the UK’s Medical Cannabis Users?
Opinion · Paul North
7 August 2024
MedBud’s July 2024 Data: UK Medical Cannabis Clinics, Pharmacies, Flower & Oil
Features · Paul North
5 July 2024
What does a Labour majority mean for UK drug policy?
Opinion · Katya Kowalski
3 July 2024
MedBud’s June 2024 Data: UK Medical Cannabis Clinics, Pharmacies, Flower & Oil
News · Katya Kowalski
24 June 2024
5 things to not miss at Cannabis Europa 2024
News · Volteface
11 June 2024
How to thrive in a rapidly changing Europe?
News · Katya Kowalski
5 June 2024
Industry News Show: UK Market Stats // Labour Gov // Police Stigma
News · Volteface
4 June 2024
MedBud’s May 2024 Data: UK Medical Cannabis Clinics, Pharmacies, Flower & Oil
News · Volteface
3 June 2024
Analysing the Evidence for Cannabis Legalisation
News · Oliver Callaghan
21 May 2024
Lion’s Mane: Exploring the Resurgence of the “Mountain Priest”
Features · Oliver Callaghan
15 May 2024
US Cannabis Rescheduling: What does the DEA Announcement Mean?
News · Oliver Callaghan
10 May 2024
Affordable care for all: Lyphe’s subscription program launches
News · Katya Kowalski
10 May 2024
Cannabis cards: what are the pros and cons?
News · Katya Kowalski
3 May 2024
Can private health insurance cover the cost of medical cannabis consultations?
News · Katya Kowalski
26 April 2024
Cannabis Colonialism: The Historical Influence of Hemp Trade in the UK
Features · Oliver Callaghan
22 April 2024
#ReleaseMyMeds campaign launched by Release to protect medical cannabis patients’ rights
News · Katya Kowalski
17 April 2024
Kratom in the US: Worsening Epidemic or a Media Scapegoat?
News · Oliver Callaghan
11 April 2024
Cannabis Industry News Show: 10 April 2024
News · Volteface
11 April 2024
The Patient Perspective: Episode 3
News · Katya Kowalski
20 March 2024
Medical Cannabis Clinic Spotlight: Releaf
Features · Katya Kowalski
19 March 2024
The Patient Perspective: Episode 2
News · Volteface
14 March 2024
Industry News Show: 13 March 2024
News · Volteface
12 March 2024
Webinar: How Can We Improve The Medical Cannabis Patient Journey in the UK?
News · Katya Kowalski
11 March 2024
Cannabis Industry News Show: 7 March 2024
News · Volteface
5 March 2024
Landmark German Cannabis Legalisation: A Window into the Future of European Drug Policy?
News · Oliver Callaghan
28 February 2024
IACM Patient Council Attends 67th Session of United Nations Commission on Narcotic Drugs
News · Oliver Callaghan
26 February 2024
How does the Script Assist ‘Find a Doctor’ feature work?
News · Volteface
23 February 2024
Thailand Seeks to Ban Recreational Cannabis
News · Oliver Callaghan
22 February 2024
Drug trends in young people: what does it suggest about their changing lifestyles?
News · Oliver Callaghan
21 February 2024
New Script Assist App launches Find a Doctor
News · Volteface
9 February 2024
How is Cannabis Reform Progressing in Ireland?
News · Volteface
9 February 2024
The weird and wonderful world of LSD
Features · Oliver Callaghan
2 February 2024
The Patient Perspective: Episode 1
News · Volteface
26 January 2024
Ukraine Approves Monumental Cannabis Legislation
News · Oliver Callaghan
25 January 2024
How does the Czech approach to legalisation compare to the US?
News · Oliver Callaghan
23 January 2024
Is the Czech Republic taking a step backwards in legalising cannabis?
News · Volteface
19 January 2024
Cannabis Industry News Show: 18 January 2024
News · Volteface
18 January 2024
Why are Brits so opposed to cannabis?
Opinion · Katya Kowalski
17 January 2024
What to Expect from US Cannabis Reform in 2024
News · Oliver Callaghan
15 January 2024
Cannabis Reform and Public Health Considerations with Alfredo Pascual
News · Volteface
10 January 2024
4C LABS Announces Launch of Village Farms’ Top-Selling Cannabis Brands in the UK
News · Volteface
4 January 2024
Everything You Need to Know About the Dutch Cannabis Experiment
News · Oliver Callaghan
2 January 2024
What can we learn from the opioid and spice epidemics?
Opinion · Oliver Callaghan